Vanguard Group’s Cryo-Cell International CCEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
129,814
+11,579
| +10% | +$60.1K | ﹤0.01% | 3855 |
|
|
2025
Q1 | $753K | Buy |
118,235
+1,279
| +1% | +$8.15K | ﹤0.01% | 3787 |
|
|
2024
Q4 | $867K | Buy |
116,956
+108
| +0.1% | +$800 | ﹤0.01% | 3809 |
|
|
2024
Q3 | $744K | Buy |
116,848
+2,069
| +2% | +$13.2K | ﹤0.01% | 3860 |
|
|
2024
Q2 | $873K | Buy |
114,779
+21,840
| +23% | +$166K | ﹤0.01% | 3837 |
|
|
2024
Q1 | $693K | Buy |
92,939
+1,800
| +2% | +$13.4K | ﹤0.01% | 3926 |
|
|
2023
Q4 | $524K | Buy |
91,139
+7,256
| +9% | +$41.7K | ﹤0.01% | 4021 |
|
|
2023
Q3 | $441K | Buy |
83,883
+10,095
| +14% | +$53.1K | ﹤0.01% | 4092 |
|
|
2023
Q2 | $449K | Buy |
73,788
+1,475
| +2% | +$8.97K | ﹤0.01% | 4148 |
|
|
2023
Q1 | $218K | Hold |
72,313
| – | – | ﹤0.01% | 4307 |
|
|
2022
Q4 | $306K | Buy |
72,313
+77
| +0.1% | +$326 | ﹤0.01% | 4220 |
|
|
2022
Q3 | $441K | Hold |
72,236
| – | – | ﹤0.01% | 4245 |
|
|
2022
Q2 | $426K | Hold |
72,236
| – | – | ﹤0.01% | 4326 |
|
|
2022
Q1 | $551K | Hold |
72,236
| – | – | ﹤0.01% | 4382 |
|
|
2021
Q4 | $838K | Buy |
+72,236
| New | +$838K | ﹤0.01% | 4310 |
|